Sign in

CIK 0001759138

  • Non-accelerated filer
  • Smaller reporting company

Cabaletta Bio, Inc.

Sign in to watch
Ticker
CABA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-759-3100
Business address
2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-09 Simon Mark Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2026-01-21 Simon Mark Director Purchase +11,061 $2.28 $25K 147,205
2025-06-09 Simon Mark Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2025-05-19 Simon Mark Director Returned to the company · Stock Option (Right to Buy) −18,460 0
2025-05-19 Simon Mark Director Grant or award · Stock Option (Right to Buy) +18,460 18,460
2025-05-19 Simon Mark Director Returned to the company · Stock Option (Right to Buy) −22,000 0
2025-05-19 Simon Mark Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2025-05-19 Simon Mark Director Returned to the company · Stock Option (Right to Buy) −22,000 0
2025-05-19 Simon Mark Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2025-05-19 Simon Mark Director Returned to the company · Stock Option (Right to Buy) −22,000 0
2025-05-19 Simon Mark Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2024-06-03 Simon Mark Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-01 Simon Mark Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2022-10-18 Simon Mark Director Purchase +118,000 $0.98 $115K 136,144
2022-10-18 Simon Mark Director Purchase +7,000 $0.98 $7K 7,000
2022-06-01 Simon Mark Director Grant or award · Stock Option (Right to buy) +22,000 22,000
2021-06-01 Simon Mark Director Grant or award · Stock Option (Right to buy) +22,000 22,000
2019-10-29 Simon Mark Director Conversion +18,144 18,144
2019-10-29 Simon Mark Director Conversion · Series A-1 Preferred Stock −27,217 0

Page 1 of 1 · 19 trades